Signatera reports | Natera

Detect residual disease before it spreads

Introducing the first ctDNA molecular monitoring tool – the sooner you know, the sooner you can act

Detect residual disease before it spreads

Introducing the first ctDNA molecular monitoring tool – the sooner you know, the sooner you can act

Detect residual disease before it spreads

Introducing the first ctDNA molecular monitoring tool – the sooner you know, the sooner you can act

Detect residual disease before it spreads

Introducing the first ctDNA molecular monitoring tool – the sooner you know, the sooner you can act

Guidance at a glance.

Easy-to-interpret longitudinal report for molecular monitoring

The Signatera ctDNA report indicates whether ctDNA status is positive or negative for the plasma sample collected and includes historical results of past ctDNA status. A ctDNA-positive status indicates that molecular residual disease is detected.

Signatera - sample report - positive

 

Signatera Billing and Customer Care: 650.489.9050
Hours of operation: Monday - Friday 7am-7pm CST and Saturday 8am-5pm CST
Email: support@natera.com 

Contact us

Back to Top